Affiliation:
1. Division of Arthritis and Rheumatic Diseases Oregon Health & Science University Portland Oregon USA
2. Innovent Biologics (USA) Rockville Maryland USA
Subject
Rheumatology,Internal Medicine,Immunology and Allergy,Immunology
Reference26 articles.
1. Long-term impact of delay in assessment of patients with early arthritis
2. Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study
3. Hydroxychloroquine does not prevent the future development of rheumatoid arthritis in a population with baseline high levels of antibodies to citrullinated protein antigens and absence of inflammatory arthritis: interim analysis of the StopRA trial [abstract];Deane K;Arthritis Rheumatol,2022
4. Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial
5. Abatacept significantly reduces subclinical inflammation during treatment (6 months), this persists after discontinuation (12 months), resulting in a delay in the clinical development of RA in patients at risk of RA (The ARIAA Study) [abstract];Rech J;Arthritis Rheumatol,2022